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The feasibility of the selective modification of the argimyl re-
sidue in insulin by the method of Patthy and Smith (J. Biol. Chem. 
250 (1975) 557-564; ibid. 565-569), involving the reversible reaction 
of cyclohexane-1,2-dicme wiith the guanidrinio function of arginine in 
a borate buffer, was studied. It was found that cyclohexane-1,2-
-di,one reacts specifically and completely Wli.th the arginyl residue of 
porcine insulin in 0.2 M borate buffer at pH = 9.0 to form a single 
addition product ([DHCH-Arg-B22]-insulin complex I) which, upon 
treatment with 0.5 M hydroxylamine at pH = 7.0, regenerated 
insulin of unchanged biological activity. Incubation of I with 
trypsin led to specific cleavage at the Lys-B29 residue to give des-
-Ala-B30-[DHCH-Arg-B22]-insulin complex II, which, upon hydro-
xylamine treatment afforded des-Ala-B30-insulin (III) in high yield. 
INTRODUCTION 
Porcine, bovine and human insulin contain a single arginyl residue 
occurring at position 22 of the B chain. Among various bifunetional reagents 
used1 in reversible modification of the arginyl residues in proteins, cyclo-
hexane-1,2-dione has attracted considerable attention2• Patthy and Smith3·' 
demonstrated the reagent that reacts completely with the guanidino function of 
arginine at pH 8-9 in sodium borate buffer to give a single product, N7,N8 -
-(l,2-dihydroxycyclohex-1,2-ylene (DHCH) arginine-borate complex, which 
could be regenerated quantitatively by strong nucleophiles, such as hydroxyl-
amine, under mild reaction conditions. They also showed that the DHCH-Arg 
residue in modified proteins is resistant to the action of trypsin, thus restrict-
ing hydrolysis to the peptide bonds involving lysine. The procedure has been 
repeatedly employed for the recognition of functionally significant arginyl 
residues in enzymes2•5, parathyroid hormone6 , serum albumin7 and lipoproteins~, 
however, to our knowledge, it has not been used so far in modification of the 
* We thank one of the referees of drawing our attention to the paper by K. 
Morihara, T. Oka, H. Tsuzuki, K. Inouye, and S. Sakakibara, presented at the 6th 
American Peptide Symposium (Summer 1979), in which the reaction of cyclohexane-
-1,2-dione with des-alanine-B3~-insulin to produce des-Ala-B30-[DHCH-Arg-B22]-
-insulin is reported. 
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insulin molecule, or as a preparative method for polypeptide fragments suitable 
in semisynthetic work.* 
In the present paper we show that cyclohexane-1 ,2-dione reacts selectively 
with the arginyl residue in the insulin molecule to give the corresponding 
DHCH-complex I which, after tryptic digestion and regeneration, gives des-
-Ala-B30 insulin in high yield. 
RESULTS AND DISCUSSION 
Treatment of porcine insu1in with 0.05 M cyclohexane-1,2-dione (a 100 fold 
excess) in 0.2 M borate buffer under nitrogen at 37 °C for 12 hr, resulted in 
a single product which was characterised as l,2-dihydroxylcyclohex-1,2-ylen 
(DHCH)-Arg-B22--insu1in complex (I) as follows . On cellogel electrophoresis, the 
product was relatively more negative and migrated slower toward the cathode 
than the untreated insulin (Figure 2.), thus suggesting the loss of the positive 
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F igu re 2. Electrophoresis on cellulose acetate (pH = 4.8, 0.1 M p yridine/6 M u rea) of (a) 
untreated (native) por cine insulin, (b) insulin treated w ith cy clohex ane-1,2-dione, and (c) insu)in 
from which cy clohex a n e -1,2-dione w as .r emoved. Conditions fo r the mqd ification and r egenera t-
ion were as described in the Experimental part. The strips were stained with Ponceau S (0.25' /o in 
3' /o t r ichloroacetic acid). 
charge from the arginyl side chain. Patthy and Smith2•3 have demonstrated that 
under conditions of conventional acid hydrolysis the DHCH-arginine-borate 
complex regenerated up to 20'0/o of arginine, whereas regeneration was prevent-
ed completely when hydrolysis was performed in the presence of thioglycolic 
acid. Accordingly, it was possible to determine the extent of modification of the 
insulin molecule by amino acid analysis of the isolated product. The finding 
that the amino acid composition (Table I) of DHCH-insulin complex I lacked 
arginine but otherwise was identical to that of untreated insulin, indicates (a) 
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complete reaction of the reagent with the guanidino function of the arginyl 
residue, and (b) no alterations in the other amino acid residues. 
Treatment of the DHCH-insulin complex I with 0.5 M hydroxylamine at 
pH = 7.0 under nitrogen at 37 °C for 1 hr, led to regeneration of the insulin 
molecule, as proved by electrophoretic mobi1ity (F'igure 2.) and amino acid 
analysts (Table I) of the product isolated in 87°/o yield. The bti.ological activity 
of the regenerated insulin was indistinguishable, as determined by the mouse 
fall test performed with two separate preparations, from that of the starting 
(untreated) insulin. When Zn-f.ree insulin was subjected to subsequent treat-
ment with cyclohexane-1,2-dione and hydroxylamine, under conditions des-
crrbed •above, the electrophoreti:c properties and amino acid analyses of the 
products were the same as those of DHCH-insulin complex I and the starting 
insulin, respectively. 
The extent of the modification of the insulin molecule with cyclohexane-1,2-
-dione as a function of the reaction time, was followed by measuring the 
amount of unmodified arginine in the hydrolysates of samples withdrawn 
from the reaction mixture at timed intervals. As shown in Figure 3., the time 
course of the react1on of the arginine guanidino function with the reagent 
TABLE I 
Amino Acid Composition of [DHCH-Arg-B 22] -insulin Complex (I), Insulin Regenerated 
from I (Ins), Des-Ala-B30-[DHCH-Arg-B22]-insulin Complex (II), and Des-Ala-B30-
-insulin (III)" 
Amino Acid Found: 
Residue" (I) (Ins) (II) (III) 
Asp (3) 3.00 3.ooc 3.00 3.00" 3.00 
Thr (2) 2.05 1.72 3.13 1.67 1.79 
Ser (3) 2.64 2.80 2.72 2.75 2.74 
Glu (7) 6.97 7.03 7.04 7.06 7.13 
Pro (1) 0.94 1.04 1.06 1.09 1.04 
Gly (4) 4.10 3.98 4.13 3.91 4.01 
Ala (2) 2.25 2.01 2.27 1.12 1.13 
Cys (6) 4.96 5.48 4.79 6.05 4.68 
Val (4) 3.22 2.94 3.17 2.97 3.19 
Ile (2) 0.95 1.06 1.09 1.00 1.11 
Leu (6) 5.82 5.97 6.03 5.93 6.14 
Tyr (4) 3.23 3.65 3.49 3.78 3.47 
Phe (3) 2.67 2.87 2.87 2.94 2.78 
His (2) 1.85 1.95 2.03 1.91 2.04 
Lys (1) 1.00 1.00 0.97 0.96 1.13 
Arg (1) < 0.2 0.00 1.04 0.00 0.92 
a The values found are given as molar ratios with respect to aspartic acid = 3.00 and they 
are not corrected for destruction. Hydrolysis of samples was performed in 6 M HCI, if not 
stated otherwise. 
" The values in brackets refer to the number of amino acid residues in native porcine 
insulin. 
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Figure 3. Plot of the percentage of unmodified arginine in hydrolysates of cyclohexane-1,2-
-dione-treated insulin as a function of the reaction time. The reaction was performed as 
described in the Experimental part, and aliquots (250 µl) were removed at each time point, 
acidified to pH ~ 3.5 and desalted on Sephadex G-50 (superfine) with 0.1 M acetic acid. Aftet 
lyophilisation of the peak tubes, the residues were subjected to acid hydrolysis (without addition 
of thioglycolic acid) and amino acid determination. 
indicates that most of the complex I formation occurred by 6 hr; for pre-
parative work, a 12 hr (overnight) incubation period was found to be most 
suitable. 
The tryptic incubation of the freshly prepared DHCH-insulin complex J 
was performed at pH = 8.0 and 37 °C for 20 hr. Fractionation of the digest on 
a Sephadex G-50 column is shown in Figure 4; no small peptides were detec-
table in the low-molecular weight fractions. Amino acid analysis (Table I) of 
the isolated (810/o) product revealed that it contained one alanyl residue less 
than the starting DHCH-complex I, thus indicating that the enzyme action 
was limited to hydrolysis of the Lys-B2.9 residue to give des-Ala-B30-[DHCH-
-Arg-B22]-insulin complex (II) as the sole product .Treatment of. II with 
hydroxylamine, followed by ultrafiltration and lyophilisation of the reaction 
mixture, afforded (85'0/o yield) des-Ala-B30-insulin (III) the amino acid com-
position of which (Table I) was fully consistent with the structure proposed. 
Des-alanine-B3°-insulin was obtained9•10 by the digestion of porcine insulin 
with carboxypeptidase A in Tris/HCl buffer, followed by separation from the 
preponderantly formed des-Ala-B30, des-Asn-A21 -insulin on DEAE Sephadex. 
Schmitt and Gattner11 improved the method by performing incubation in 0.1 M 
ammonium hydrogen carbonate at pH = 8.2; under these conditions, only 
alanine was liberated to give, upon desalting and fractionation of the product 
on DEAE Sephadex ,des-Ala-B30-insulin in high yield. The present route, 

















Figure 4. Sephadex G-50 (superfine , 2.5 X 70 cm) elution pattern of the tryptic digest of 
[DHCH-Arg-B" J-insulin with 0.1 M acetic acid (flow rate: 15 m l/hr, fractions: 3 ml) . The peak 
fractions w ere pooled as indicated, concentrated and Jyophilised to give des-alanine-B'"-
-[DHCH-Arg-B"]-insulin (II, 32.4 mg, 81'/o). v. v. ~ -void volume . 
blocking with cyclohexane-1,2-dione, offers a new and simple means for 
preparing des-Ala-B30-insulin. The mild conditions used in this procedure, the 
specificity of the reaction and homogeneity of the products, suggest its possible 




Porcine insulin, crystalline, zinc-salt, was obtained from PLIVA (lot No 
4,047,022, 24.4 I. U./mg) and was. used throughout. Zn-free insulin was prepared after 
Slyterman12 as already described13 . Cyclohexane-1,2-dione and trypsin (bovine, Type 
XI, chymotrypsin free) were obtained from Sigma, hydroxylamine hydrochloride 
p. a. from Merck, and thiglycolic acid puriss. from Fluka. 
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Methods 
All separations on columns were carried out at 4 °C. Products were recovered 
by evaporation of the eluates to small volumes (rotary evaporator, bath temp. 
< 35 °C), followed by lyophilisation. 
Electrophoresis on cellulose acetate was performed on strips (2.5 X 14 cm) in 
a standard electrophoresis apparatus (Chemetron) at 200 V and at pH 4.8 (0.1 M 
pyridine/6 M urea buffer adjusted with acetic acid). The strips were stained with 
0.250/o solution of Ponceau S in 30/o trichloroacetic acid. 
Amino acid analyses were made using a LKB automatic amino acid analyzer, 
model BC 200. Hydrolyses were performed in 6 M HCl, in the presence (20 µl) and 
absence of thioglycolic acid, in sealed tubes at 110 °c for 14 hr. Samples were added 
in 0.2 M sodium citrate buffer (pH 2.2), and analyses were run at 55 °C with three 
sodium citrate buffers: (1) 0.2 M, pH = 3.25, (2) 0.2 M, pH= 4.25, and (3) 1.2 M, 
pH = 6.45. In kinetic measurements only the basic amino acids were determined. 
[DHCH-Arg-B22]-insulin (I) 
To a solution of cyclohexane-1,2-dione (112 mg, 1 mmol) in 0.2 M sodium borate 
buffer, pH = 9.0 (18 ml) was added under a slow stream of nitrogen, Zn-insulin 
(50 mg, 9.4 µmol) dissolved in the same buffer (18 ml), and the reaction mixture 
(insulin concentration 3 mg/ml) was incubated under nitrogen at 37 °c for 12 hr. 
The reaction was stopped by addition of 1 M acetic acid to pH= 3.5 (- 5 ml), and 
the solution was concentrated and passed through a column of Sephadex G-50 
(superfine, 2.5 X 40 cm) equilibrated with 0.1 M acetic acid and eluted with the 
same solvent (flow rate: 20 ml/hr. fractions: 3 ml). The peak tubes (monitoring by 
absorption at 280 nm) were pooled and lyophilised to give 46.3 mg (920/o) of fluffy 
material which was characterised (Table I, Figure 2.) as I free of the starting 
insulin. 
When a sample (20 mg) of Zn-free insulin was treated exactly as described 
above, the final product (18 mg, 900/o) showed no difference from I, as judged by the 
electrophoretic mobility and amino acid analysis. 
Regeneration of Insulin from Complex I 
The freshly prepared complex I (20 mg) was dissolved in 0.5 M hydroxylamine 
(15 ml), the solution was adjusted (M NaOH) to pH = 7.0 and incubated under a 
slow stream of nitrogen at 37 °c for 12 hr. After addition of M acetic acid to pH = 3.5, 
the solution was concentrated ( - 5 ml), and the concentrate was passed through a 
Sephadex G-50 column (superfine, 2.5 X 40 cm) with 0.1 .M acetic acid. Concentration 
and lyophilisation of the pooled peak tubes (monitoring by absorption at 280 nm), 
afforded insulin (17.5 mg, 870/o) the electrophoretic mobility (Figure 2.), amino acid 
analysis (Table I) and biological activity of which were indistinguishable from those 
of the starting (untreated) insulin. 
Tryptic Hydrolysis of I Into des-Ala-B30-[DHCH-Arg-B22 ]-insulin (II) 
A solution of the freshly prepared complex I (40 mg, 7.5 ~tmol) in 0.1 M borate 
buffer, pH = 8.0 (8 ml) was incubated with trypsin (0.8 mg, ratio enzyme : substrate 
1 : 50) at 37 °c for 20 hr. The digestion was arrested by adding M acetic acid to 
pH = 3.5, and, after concentration, the material was subjected to fractionation on 
Sephadex G-50 as described in Figure 4. Lyophilisation of the peak tubes afforded II 
(32.4 mg, 81 O/o) as a fluffy mass which was characterised by amino acid analysis 
(Table I). 
Des-Ala-B 30-insulin (III) 
The complex (II) (30 mg) was treated with 0.5 M hydroxylamine (25 ml) as 
described for the regeneration of insulin from I. The digest, after acidification to 
pH = 3.5, was diluted to 30 ml with 150/o acetic acid, and the solution was freed from 
small molecules and concentrated (- 5 ml) in an Amicon stirred cell with a UM-2 
membrane (nominal cut off at 1,000 daltons) by subsequent filtration with 15, 10 and 
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60/o acetic acid (25 ml each). Lyophilisation of the concentrate left 25.6 mg (850/o) of 
a fluffy mass which was characterised (Table I) as the title compound (III). 
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SAZETAK 
Priprava des-Ala-B30-insulina putem tripticke hidrolize svinjskog insulina kojemu 
je blokiran arginil ostatak sa cikloheksan-1,2-dionom 
B. Mulac i D. Keglevic 
Pokazano je da cikloheksan-1,2-dion reagira selektivno, i pod vrlo blagim reak-
cionim uvjetima, sa guanidino funkcijom arginil ostatka u molekuli insulina . Reak-
cija se provodi u 0.2 M borat puferu, pH = 9.0 kod 37 °c, a iz nastalog kompleksa 
tretiranjem sa hidroksila minom (0.5 M, pH = 7.0) regenerira se insulin nepromije-
njene bioloske aktivnosti. Inkubacija izoliranog kompleksa I sa tripsinom rezultirala 
je u iskljucivom cijepanju veze Lys-B29-Ala-B"~ posto je reverzibilno blokiranje 
arginil ostatka (B22) sa cikloheksan-1,2-dionom sprijecilo normalnu ataku enzima na 
polofaj Arg-B22-Gly-B23• Tretiranjem enzimskog produkta sa hidroksilaminom dobi-
ven je des-Ala-B30-insulin u cistom stanju i visokom iskoristenju. Produkti opisanih 
reakcija karakterizirani su analizom aminokiselina, elektroforetskom pokretljivoscu, 
i u slucaju regeneriranog insulina bioloskom aktivnoscu. 
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